Roche Gets FDA Clearance for Highly Sensitive B-cell Lymphoma Test
A new test for Roche received FDA clearance as a sensitive diagnostic tool to differentiate B-cell lymphomas for improved diagnosis.
Category: Lymphoma
Lymphoma
Latest
Lymphoma
Latest
Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Lymphoma
Latest
Immunohistochemistry Test Detects ROS1 Protein in Cancer
The biomarker may provide a cost-effective and efficient means to identify elevated ROS1 protein expression in cancer.
ASCP, ASH, and CAP Invite Public Comment on Lymphoma Guideline
Multidisciplinary guidance document focuses on specimen requirements for the diagnosis of lymphoma.
Read More
August/September 2017 Product Spotlight: New Products Showcase
This month’s Product Spotlight features new products from such companies as Advanced Instruments, Beckman Coulter, and Thermo Fisher Scientific.
Read More
HTG Molecular Diagnostics Launches NGS-Based Cell-of-Origin Assay for Diffuse Large B-Cell Lymphomas
HTG’s next-generation sequencing assay enables subtyping of DLBCL as activated B-cell-like or germinal center B-cell-like.
Read More
NCI Awards $1.4 Million Grant to Advanced Cell Diagnostics
Under a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.
Read MorePathGroup Collaboration to Offer Genomic Profiling of Hematologic Malignancies
A new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read MoreTool Could Help Assessment of Hodgkin’s Lymphoma and Breast Cancer
A new study shows the MultiOmyx profile could improve disease assessment for both diseases using multiplex proteins.
Read More
Sequenta Expands Sample Types Accepted for ClonoSIGHT MRD Test for Leukemia, Lymphoma
Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.
Read More
Diagnovus Debuts Gene Expression Assay for Patients With Diffuse Large B-Cell Lymphoma
Assay can aid physicians in better risk stratification and treatment of patients with diffuse large B-cell lymphoma.
Read More
Sequenta Introduces ClonoSIGHT, Sequencing-Based MRD Test for Leukemia, Lymphoma
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.
Read MoreTesting for Lymphoma and Leukemia
With so many types of lymphoma, there’s a wide range of corresponding lab tests to detect their presence in patients. Here, CLP takes a look at testing for the most common type of lymphoma (diffuse large B-cell
Read More